Ulagamadesan Venkatesan (Hertzel C Gerstein, Hertzel C Gerstein, Hertzel Gerstein)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 94

Top Topics

Randomized Controlled Trial

Cardiovascular Events

Atrial Fibrillation

Top Venues

Diabetes, obesity & metabolism

Journal of diabetes

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ulagamadesan Venkatesan, Mu Yang, Shun Fu Lee, Kelley R H Branch, Stephano Del Prato, Carolyn Su Ping Lam, Renato D Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar
Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE-O trial. Diabetes, obesity & metabolism (2024)
Omri Segev, Itamar Raz, Ulagamadesan Venkatesan, Hillel Aviezer, Yael Sela, Dani Cukierman, Rahul Shankar, Rachel Natovich, Tali Cukierman-Yaffe
Development and first-stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes. Diabetes, obesity & metabolism 26 (8) (2024)
Kamel Mohammedi, Sibylle Hess, Matthew McQueen, Marie Pigeyre, Shun Fu Lee, Guillaume Pare, Ulagamadesan Venkatesan
Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial. Diabetes, obesity & metabolism 26 (8) (2024)
Kamel Mohammedi, Marie Pigeyre, Jackie Bosch, Salim Yusuf, Ulagamadesan Venkatesan
Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study. European heart journal (2024)
Kamel Mohammedi, Marie Pigeyre, Jackie Bosch, Salim Yusuf, Ulagamadesan Venkatesan
Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study. European heart journal 45 (19) (2024)
Kamel Mohammedi, Marie Pigeyre, Jackie Bosch, Salim Yusuf, Ulagamadesan Venkatesan
Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study. European heart journal 45 (19) (2024)
Tali Cukierman-Yaffe, Chinthanie Ramasundarahettige, Jackie Bosch, Ulagamadesan Venkatesan
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial. Diabetes, obesity & metabolism 26 (4) (2024)
Kamel Mohammedi, Sibylle Hess, Matthew McQueen, Marie Pigeyre, Shun Fu Lee, Guillaume Pare, Ulagamadesan Venkatesan
Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial. Diabetes, obesity & metabolism (2024)
Brendon L Neuen, Robert A Fletcher, Lauren Heath, Adam Perkovic, Muthiah Vaduganathan, Sunil V Badve, Katherine R Tuttle, Richard E Pratley, Ulagamadesan Venkatesan, Vlado Perkovic, Hiddo J Lambers Heerspink
Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Circulation (2024)
Chang Ye, Jiajie Pu, Chang Ye, Alexandra Emery, Stewart B Harris, Sonja M Reichert, Ulagamadesan Venkatesan, Natalia McInnes, Caroline Kaercher Kramer, Bernard Zinman
A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity. Diabetes care (2024)
Omri Segev, Itamar Raz, Ulagamadesan Venkatesan, Hillel Aviezer, Yael Sela, Dani Cukierman, Rahul Shankar, Rachel Natovich, Tali Cukierman-Yaffe
Development and first-stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes. Diabetes, obesity & metabolism (2024)
Chang Ye, Sangeeta R Kashyap, Ulagamadesan Venkatesan, Vanita R Aroda
Contemporary Clinical Perspectives on Targeting Remission of Type 2 Diabetes. The Journal of clinical endocrinology and metabolism 109 (5) (2024)
Tali Cukierman-Yaffe, Chinthanie Ramasundarahettige, Jackie Bosch, Ulagamadesan Venkatesan
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial. Diabetes, obesity & metabolism 26 (4) (2024)
Zubin Punthakee, Stephanie Hall, Natalia McInnes, Diana Sherifali, Kate Tsiplova, Faith R Kirabo, Thomas P P Ransom, Stewart B Harris, Heather A Lochnan, Ronald J Sigal, Mahua Ghosh, Tamara Spaic, Ulagamadesan Venkatesan, null null
Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial. Diabetes, obesity & metabolism (2024)
Tali Cukierman-Yaffe, Chinthanie Ramasundarahettige, Jackie Bosch, Ulagamadesan Venkatesan
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial. Diabetes, obesity & metabolism (2024)
Tali Cukierman-Yaffe, Chinthanie Ramasundarahettige, Jackie Bosch, Ulagamadesan Venkatesan
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial. Diabetes, obesity & metabolism 26 (4) (2024)
Liam Mc Morrow, Frauke Becker, Ruth L Coleman, Ulagamadesan Venkatesan, Lars Rydén, Stefan Schöder, Alastair M Gray, Shelby D Reed, Rury R Holman, null null
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial. Journal of diabetes (2023)
Fady T Botros, Ulagamadesan Venkatesan, Raleigh Malik, Claudia Nicolay, Anastasia Hoover, Ibrahim Turfanda, Helen Martina Colhoun, Jonathan E Shaw
Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis. Diabetes care (2023)
Reema Shah, Jeremy Petch, Walter Nelson, Karsten Roth, Michael D Noseworthy, Marzyeh Ghassemi, Ulagamadesan Venkatesan
Nailfold capillaroscopy and deep learning in diabetes. Journal of diabetes (2023)
Ulagamadesan Venkatesan, Rajibul Mian, Chinthanie Ramasundarahettige, Kelley R H Branch, Stephano Del Prato, Carolyn Su Ping Lam, Renato D Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial. Diabetes, obesity & metabolism 26 (4) (2023)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism 25 (4) (2023)
Ulagamadesan Venkatesan, Zhuoru Li, Chinthanie Ramasundarahettige, SeungJae Baek, Kelley R H Branch, Stephano Del Prato, Carolyn Su Ping Lam, Renato Deláscio Lopes, Richard E Pratley, Julio Rosenstock, Naveed Sattar
Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. Circulation (2023)
Ruoting Wang, Ulagamadesan Venkatesan, Harriette Gillian Christine Van Spall, Gregory Yoke Hong Lip, Ivan Olier, Sandra Ortega-Martorell, Lehana Thabane, Zebing Ye, Guowei Li
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: reply. European heart journal. Quality of care & clinical outcomes (2023)
Reema Shah, Jeremy Petch, Walter Nelson, Karsten Roth, Michael D Noseworthy, Marzyeh Ghassemi, Ulagamadesan Venkatesan
Nailfold capillaroscopy and deep learning in diabetes. Journal of diabetes 15 (2) (2023)
Lena Tschiderer, Lisa Seekircher, Raffaele Izzo, Costantino Mancusi, Maria Virginia Manzi, Damiano Baldassarre, Mauro Amato, Elena Tremoli, Fabrizio Veglia, Tomi-Pekka Tuomainen, Jussi Kauhanen, Ari Voutilainen, Bernhard Iglseder, Lars Lind, Tatjana Rundek, Moise Desvarieux, Akihiko Kato, Eric de Groot, Gülay Aşçi, Ercan Ok, Stefan Agewall, Joline Wilhelma Johanna Beulens, Christopher D Byrne, Philip C Calder, Ulagamadesan Venkatesan, Paolo Gresele, Gerhard Klingenschmid, Michiaki Nagai, Michaels Hecht Olsen, Grace Parraga, Maya S Safarova, Naveed Sattar, Michael R Skilton, Coen D A Stehouwer, Heiko Uthoff, Michiel A van Agtmael, Amber A van der Heijden, Dorota A Zozulinska-Ziolkiewicz, Hyun-Woong Park, Moo-Sik Lee, Jang Ho Bae, Oscar Beloqui, Manuel F Landecho, Matthieu Plichart, Pierre Ducimetiere, Jean Philippe Empana, Lena Bokemark, Göran Bergstrom, Caroline Schmidt, Samuela Castelnuovo, Laura Calabresi, Giuseppe Danilo Norata, Liliana Grigore, Alberico Luigi Catapano, Dong Zhao, Miao Wang, Jing Liu, Mohammad Arfan Ikram, Maryam Kavousi, Michiel L Bots, Michael J Sweeting, Matthias W Lorenz, Peter Willeit, null null
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies. Journal of the American Heart Association (2023)
Chang Ye, Sangeeta R Kashyap, Ulagamadesan Venkatesan, Vanita R Aroda
Contemporary Clinical Perspectives on Targeting Remission of Type 2 diabetes. The Journal of clinical endocrinology and metabolism (2023)
Natalia McInnes, Stephanie Hall, Heather A Lochnan, Stewart B Harris, Zubin Punthakee, Ronald J Sigal, Irene Hramiak, Mohammed Azharuddin, Joanne F Liutkus, Jean-François Yale, Farah Sultan, Ada Smith, Rose E Otto, Diana Sherifali, Yan Yun Liu, Ulagamadesan Venkatesan, null null
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. Diabetes, obesity & metabolism (2023)
Harry Hezhou Wang, Michael Chong, Nicolas Perrot, James Feiner, Sibylle Hess, Salim Yusuf, Ulagamadesan Venkatesan, Guillaume Paré, Marie Pigeyre
Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk. Diabetes care (2023)
Chang Ye, Jiajie Pu, Alexandra Emery, Stewart B Harris, Sonja M Reichert, Ulagamadesan Venkatesan, Natalia McInnes, Caroline K Kramer, Bernard Zinman
Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes. Nature communications 14 (1) (2023)
Reema Shah, Jeremy Petch, Walter Nelson, Karsten Roth, Michael D Noseworthy, Marzyeh Ghassemi, Ulagamadesan Venkatesan
Nailfold capillaroscopy and deep learning in diabetes. Journal of diabetes 15 (2) (2023)
Rosain N Stennett, Kristi B Adamo, Sonia S Anand, Harpreet S Bajaj, Shrikant Ishver Bangdiwala, Dipika Desai, Ulagamadesan Venkatesan, Sujane Kandasamy, Farah Khan, Scott A Lear, Sarah D McDonald, Tayler Pocsai, Paul Ritvo, Andrea Rogge, Karleen M Schulze, Diana Sherifali, Jennifer C Stearns, Gita Wahi, Natalie C Williams, Michael A Zulyniak, Russell J de Souza
A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol. BMJ open 13 (5) (2023)
Naveed Sattar, John Joseph Valentine McMurray, Jan Borén, Araz Rawshani, Elmir Omerovic, Niklas Berg, Janita Holminen, Kristoffer Skoglund, Bjorn Eliasson, Ulagamadesan Venkatesan, Darren K McGuire, Deepak L Bhatt, Aidin Rawshani
Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study. Circulation (2023)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism 25 (4) (2023)
Ulagamadesan Venkatesan, Rajibul Mian, Chinthanie Ramasundarahettige, Kelley R H Branch, Stephano Del Prato, Carolyn Su Ping Lam, Renato D Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial. Diabetes, obesity & metabolism (2023)
Ruoting Wang, Ulagamadesan Venkatesan, Harriette Gillian Christine Van Spall, Gregory Y H Lip, Ivan Olier, Sandra Ortega-Martorell, Lehana Thabane, Zebing Ye, Guowei Li
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. European heart journal. Quality of care & clinical outcomes (2023)
Rosain N Stennett, Kristi B Adamo, Sonia S Anand, Harpreet S Bajaj, Shrikant Ishver Bangdiwala, Dipika Desai, Ulagamadesan Venkatesan, Sujane Kandasamy, Farah Khan, Scott A Lear, Sarah D McDonald, Tayler Pocsai, Paul Ritvo, Andrea Rogge, Karleen M Schulze, Diana Sherifali, Jennifer C Stearns, Gita Wahi, Natalie C Williams, Michael A Zulyniak, Russell J de Souza
A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol. BMJ open 13 (5) (2023)
Ulagamadesan Venkatesan, Shun-Fu Lee, Guillaume Paré, M Angelyn Bethel, Helen Martina Colhoun, Anastasia Hoover, Mark Lakshmanan, Yanzhu Lin, Valentino Pirro, Hui-Rong Qian, Giacomo Ruotolo, Lars Ryden, Jonathan M Wilson, Kevin L Duffin
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis. Diabetes care (2023)
Reema Shah, Jeremy Petch, Walter Nelson, Karsten Roth, Michael D Noseworthy, Marzyeh Ghassemi, Ulagamadesan Venkatesan
Nailfold capillaroscopy and deep learning in diabetes. Journal of diabetes 15 (2) (2023)
Dongdong Wang, Logan K Townsend, Geneviève J DesOrmeaux, Sara M Frangos, Battsetseg Batchuluun, Lauralyne Dumont, Rune Ehrenreich Kuhre, Elham Ahmadi, Sumei Hu, Irena A Rebalka, Jaya Gautam, Maria Joy Therese Jabile, Chantal A Pileggi, Sonia Rehal, Eric M Desjardins, Evangelia E Tsakiridis, James S V Lally, Emma Sara Juracic, A Russell Tupling, Ulagamadesan Venkatesan, Guillaume Paré, Theodoros Tsakiridis, Mary-Ellen Harper, Thomas J Hawke, John R Speakman, Denis P Blondin, Graham P Holloway, Sebastian Beck Jørgensen, Gregory R Steinberg
GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature (2023)
Rosain N Stennett, Kristi B Adamo, Sonia S Anand, Harpreet S Bajaj, Shrikant Ishver Bangdiwala, Dipika Desai, Ulagamadesan Venkatesan, Sujane Kandasamy, Farah Khan, Scott A Lear, Sarah D McDonald, Tayler Pocsai, Paul Ritvo, Andrea Rogge, Karleen M Schulze, Diana Sherifali, Jennifer C Stearns, Gita Wahi, Natalie C Williams, Michael A Zulyniak, Russell J de Souza
A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol. BMJ open 13 (5) (2023)
Ulagamadesan Venkatesan, Rajibul Mian, Chinthanie Ramasundarahettige, Kelley R H Branch, Stephano Del Prato, Carolyn Su Ping Lam, Renato D Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial. Diabetes, obesity & metabolism 26 (4) (2023)
Rosain N Stennett, Kristi B Adamo, Sonia S Anand, Harpreet S Bajaj, Shrikant Ishver Bangdiwala, Dipika Desai, Ulagamadesan Venkatesan, Sujane Kandasamy, Farah Khan, Scott A Lear, Sarah D McDonald, Tayler Pocsai, Paul Ritvo, Andrea Rogge, Karleen M Schulze, Diana Sherifali, Jennifer C Stearns, Gita Wahi, Natalie C Williams, Michael A Zulyniak, Russell J de Souza
A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol. BMJ open 13 (5) (2023)
Rosain N Stennett, Kristi B Adamo, Sonia S Anand, Harpreet S Bajaj, Shrikant Ishver Bangdiwala, Dipika Desai, Ulagamadesan Venkatesan, Sujane Kandasamy, Farah Khan, Scott A Lear, Sarah D McDonald, Tayler Pocsai, Paul Ritvo, Andrea Rogge, Karleen M Schulze, Diana Sherifali, Jennifer C Stearns, Gita Wahi, Natalie C Williams, Michael A Zulyniak, Russell J de Souza
A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol. BMJ open 13 (5) (2023)
Reema Shah, Jeremy Petch, Walter Nelson, Karsten Roth, Michael D Noseworthy, Marzyeh Ghassemi, Ulagamadesan Venkatesan
Nailfold capillaroscopy and deep learning in diabetes. Journal of diabetes 15 (2) (2023)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism 25 (4) (2023)
Andrew Mente, Mahshid Dehghan, Sumathy Rangarajan, Martin O'Donnell, Weihong Hu, Gilles Dagenais, Andreas Wielgosz, Scott A Lear, Li Wei, Rafael Diaz, Álvaro Avezum, Patricio López-Jaramillo, Fernando Tomás Lanas Zanetti, Sumathi Swaminathan, Manmeet Kaur, K Vijayakumar, Viswanathan Mohan, Rajeev Gupta, Andrzej Szuba, Romaina Iqbal, Rita Yusuf, Noushin Mohammadifard, Rasha Khatib, Nafiza Mat Nasir, Kubilay Karsidag, Annika Rosengren, Afzalhussein M Yusufali, Edelweiss Wentzel-Viljoen, Jephat Chifamba, Antonio Dans, Khalid F Alhabib, Karen Yeates, Koon Teo, Ulagamadesan Venkatesan, Salim Yusuf
Diet, cardiovascular disease, and mortality in 80 countries. European heart journal (2023)
Reema Shah, Lehana Thabane, Ulagamadesan Venkatesan
Are U-shaped relationships between risk factors and outcomes artifactual? Journal of diabetes (2022)
Ulagamadesan Venkatesan
Shouldn't Preventing Type 2 Diabetes Also Prevent Its Long-Term Consequences? Circulation 145 (22) (2022)
Anita Y M Kwan, Ulagamadesan Venkatesan, Jan Basile, Denis Xavier, Juan M Maldonado, Sohini Raha, Manige Konig
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial. Diabetes care 45 (3) (2022)
Irene Hramiak, Ulagamadesan Venkatesan, Lawrence Alan Leiter, Jean-François Yale, Harpreet S Bajaj, John Stewart, Marie-Josée Toutounji, Stewart B Harris
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial. Diabetes, obesity & metabolism 24 (10) (2022)
Carolyn Su Ping Lam, Ulagamadesan Venkatesan, null null
Response by Lam and Gerstein to Letter Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial". Circulation 146 (2) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2022)
Peter Johann Raubenheimer, William C Cushman, Alvaro Avezum, Jan Basile, Ignacio Conget Donlo, Gilles R Dagenais, Anastasia Hoover, Petr Jansky, Fernando Lanas, Lawrence A Leiter, Patricio Lopez-Jaramillo, Nana Pogosova, Jeffrey Probstfield, Purnima Rao-Melacini, Lars Rydén, Wayne H-H Sheu, Theodora Temelkova-Kurktschiev, Ulagamadesan Venkatesan
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Diabetes, obesity & metabolism 24 (4) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (2) (2022)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism (2022)
Shuang Di, Jeremy Petch, Ulagamadesan Venkatesan, Ruoqing Zhu, Diana Sherifali
Optimizing Health Coaching for Patients With Type 2 Diabetes Using Machine Learning: Model Development and Validation Study. JMIR formative research 6 (9) (2022)
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Ulagamadesan Venkatesan, Stewart B Harris, Irene Hramiak, John Stewart, Lawrence Alan Leiter
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Inbar Zucker, Yair Zloof, Aya Bardugo, Avishai Michael Tsur, Miri Lutski, Yaron Cohen, Tali Cukierman-Yaffe, Noga Minsky, Estela Derazne, Dorit Tzur, Cheli Melzer Cohen, Orit Pinhas-Hamiel, Gabriel Chodick, Itamar Raz, Arnon Afek, Ulagamadesan Venkatesan, Amir Tirosh, Gilad Twig
Obesity in late adolescence and incident type 1 diabetes in young adulthood. Diabetologia 65 (9) (2022)
Raymond Q Migrino, Ulagamadesan Venkatesan, Paul J Beisswenger, Peter D Reaven
Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691. Diabetes care 45 (6) (2022)
Edward Franek, Ulagamadesan Venkatesan, Matthew C Riddle, Claudia Nicolay, Ana Hickey, Fady T Botros, Li Shen Loo
Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial. Diabetes, obesity & metabolism 24 (9) (2022)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Kober, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial. Diabetes, obesity & metabolism (2022)
Ulagamadesan Venkatesan, Sibylle Hess, Brian Claggett, Kenneth Dickstein, Lars Kober, Aldo P Maggioni, John Joseph Valentine McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study. Diabetes care 45 (9) (2022)
Kelley R H Branch, Gilles R Dagenais, Álvaro Avezum, Jan Basile, Ignacio Conget Donlo, William C Cushman, Petr Jansky, Mark Lakshmanan, Fernando Tomás Lanas Zanetti, Lawrence Alan Leiter, Prem Pais, Nana Pogosova, Peter Johann Raubenheimer, Lars Ryden, Jonathan Edward Shaw, Wayne Huey Herng Sheu, Theodora Temelkova-Kurktschiev, M Angelyn Bethel, Ulagamadesan Venkatesan, Ramasundarahettige Chinthanie, Jeffrey L Probstfield
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial. European journal of heart failure 24 (10) (2022)
Tali Cukierman-Yaffe, Ulagamadesan Venkatesan, Jan Basile, M Angelyn Bethel, Ernesto G Cardona-Muñoz, Ignacio Conget Donlo, Gilles Dagenais, Edward Franek, Stephanie Hall, Nicolae Hancu, Petr Jansky, Mark Lakshmanan, Fernando Tomás Lanas Zanetti, Lawrence Alan Leiter, Patricio López-Jaramillo, Valdis Pirags, Nana Pogosova, Jeffrey L Probstfield, Purnima Rao-Melacini, Chinthanie Ramasundarahettige, Peter J Raubenheimer, Matthew C Riddle, Lars Rydén, Jonathan E Shaw, Wayne H-H Sheu, Theodora Temelkova-Kurktschiev
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial. The Journal of clinical endocrinology and metabolism 107 (8) (2022)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip R Schauer, Roy Taylor, Douglas Twenefour
Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia 64 (11) (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip R Schauer, Roy Taylor, Douglas Twenefour
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes care (2021)
Ulagamadesan Venkatesan, Chinthanie Ramasundarahettige, Shrikant I Bangdiwala
Creating Composite Indices From Continuous Variables for Research: The Geometric Mean. Diabetes care 44 (5) (2021)
Ulagamadesan Venkatesan, Naveed Sattar, Julio Rosenstock, Chinthanie Ramasundarahettige, Richard Pratley, Renato D Lopes, Carolyn S P Lam, Nardev S Khurmi, Laura Heenan, Stefano Del Prato, Leanne Dyal, Kelley Branch, null null
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. The New England journal of medicine 385 (10) (2021)
Chang Ye, Alexandra Emery, Chang Ye, Stewart B Harris, Sonja M Reichert, Natalia McInnes, Ulagamadesan Venkatesan, Kevin E Thorpe, Caroline Kaercher Kramer, Bernard Zinman
Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trial. Diabetes, obesity & metabolism 23 (8) (2021)
Natalia McInnes, Stephanie Hall, Irene Hramiak, Ronald J Sigal, Ronald M Goldenberg, Nikhil Gupta, Remi Rabasa-Lhoret, Manoela Braga, Vincent Woo, Farah Sultan, Rose Otto, Ada Smith, Diana Sherifali, Yan Yun Liu, Ulagamadesan Venkatesan, null null, null null
Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial. Diabetes care (2021)
M Angelyn Bethel, Rafael Diaz, Noelia Castellana, Indranil Bhattacharya, Ulagamadesan Venkatesan, Mark C Lakshmanan
HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression. Diabetes care 44 (1) (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip Schauer, Roy Taylor, Douglas Twenefour
Consensus report: Definition and interpretation of remission in type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip R Schauer, Roy Taylor, Douglas Twenefour
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism (2021)
Giulia Ferrannini, Ulagamadesan Venkatesan, Helen Martina Colhoun, Gilles R Dagenais, Rafael Diaz, Leanne Dyal, Mark Lakshmanan, Linda Mellbin, Jeffrey L Probstfield, Matthew Casey Riddle, Jonathan Edward Shaw, Alvaro Avezum, Jan Neil Basile, William C Cushman, Petr Jansky, Mátyás Keltai, Fernando Tomás Lanas Zanetti, Lawrence Alan Leiter, Patricio López-Jaramillo, Prem Pais, Valdis Pīrāgs, Nana Pogosova, Peter Johann Raubenheimer, Wayne Huey-Herng Sheu, Lars Rydén
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin. European heart journal 42 (26) (2021)
Ranjit Mohan Anjana, Viswanathan Mohan, Sumathy Rangarajan, Hertzel C Gerstein, Ulagamadesan Venkatesan, Patrick Sheridan, Gilles R Dagenais, Scott A Lear, Koon Teo, Kubilay Karsidag, Khalid F Alhabib, Khalid Yusoff, Noorhassim Ismail, Prem K Mony, Patricio Lopez-Jaramillo, Jephat Chifamba, Lia M Palileo-Villanueva, Romaina Iqbal, Afzalhussein Yusufali, Afzalhussein M Yusufali, Annika Rosengren, Ahmad Bahonar, Katarzyna Zatonska, Karen Yeates, Rajeev Gupta, Wei Li, Lihua Hu, M Omar Rahman, P V M Lakshmi, Thomas Iype, Alvaro Avezum, Rafael Diaz, Fernando Lanas, Salim Yusuf
Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study. Diabetes care 43 (12) (2020)
Matthew C Riddle, Lawrence Blonde, Ulagamadesan Venkatesan, Edward W Gregg, Rury R Holman, John M Lachin, Gregory A Nichols, Alexander Turchin, William T Cefalu
Diabetes Care Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes care 42 (6) (2020)
Marie Pigeyre, Jennifer Sjaarda, Michael Chong, Sibylle Hess, Jackie Bosch, Salim Yusuf, Ulagamadesan Venkatesan, Guillaume Paré
ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study. Diabetes care 43 (4) (2020)
Yaling Tang, Hetal S Shah, Carlos Roberto Bueno Junior, Xiuqin Sun, Joanna Mitri, Maria Sambataro, Luisa Sambado, Ulagamadesan Venkatesan, Vivian A Fonseca, Alessandro Doria, Pradipta R Ray
Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial. Diabetes care 44 (1) (2020)
Ulagamadesan Venkatesan, Kelley Branch, Laura Heenan, Stephano Del Prato, Nardev S Khurmi, Carolyn S P Lam, Richard Pratley, Julio Rosenstock, Naveed Sattar
Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonist. Diabetes, obesity & metabolism 23 (2) (2020)
Mario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, Petra A Lenzini, Hannah Campbell, Allison A Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi, Marcus G Pezzolesi, Ronald J Sigal, Guillaume Paré, Santica M Marcovina, Daniel M Rotroff, Elisabetta Patorno, Luana Mercuri, Vincenzo Trischitta, Emily Y Chew, Peter Kraft, John B Buse, Michael J Wagner, Sharon Cresci, Ulagamadesan Venkatesan, Henry N Ginsberg, Josyf C Mychaleckyj, Alessandro Doria
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid. Diabetes 69 (4) (2020)
Gilad Twig, Inbar Zucker, Arnon Afek, Tali Cukierman-Yaffe, Cole D Bendor, Estela Derazne, Miri Lutski, Tammy Shohat, Ofri Mosenzon, Dorit Tzur, Orit Pinhas-Hamiel, Shmuel Tiosano, Itamar Raz, Ulagamadesan Venkatesan, Amir Tirosh
Adolescent Obesity and Early-Onset Type 2 Diabetes. Diabetes care 43 (7) (2020)
Boris Fishman, Ehud Grossman, Inbar Zucker, Omri Orr, Miri Lutski, Aya Bardugo, Cole D Bendor, Yoav Leiba, Tali Cukierman-Yaffe, Estela Derazne, Ofri Mosenzon, Dorit Tzur, Zivan Beer, Orit Pinhas-Hamiel, Tamar Fishman, Arnon Afek, Amir Tirosh, Itamar Raz, Ulagamadesan Venkatesan, Gilad Twig
Adolescent Hypertension and Risk for Early-Onset Type 2 Diabetes: A Nationwide Study of 1.9 Million Israeli Adolescents. Diabetes care 44 (1) (2020)
Ulagamadesan Venkatesan, Ruth L Coleman, Charles A B Scott, Shishi Xu, Jaakko Tuomilehto, Lars Ryden, Rury R Holman, null null
Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial. Diabetes care 43 (9) (2020)
Matthew C Riddle, Ulagamadesan Venkatesan
The Cardiovascular Legacy of Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study. Diabetes care 42 (7) (2019)
Ulagamadesan Venkatesan, Guillaume Paré, Matthew J McQueen, Shun Fu Lee, Shrikant I Bangdiwala, Aimo Kannt, Sibylle Hess, null null
Novel Biomarkers for Change in Renal Function in People With Dysglycemia. Diabetes care 43 (2) (2019)
Kristina S Boye, Matthew C Riddle, Ulagamadesan Venkatesan, Reema Mody, Luis-Emilio Garcia-Perez, Chrisanthi A Karanikas, Maureen J Lage, Jeffrey S Riesmeyer, Mark C Lakshmanan
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States. Diabetes, obesity & metabolism 21 (6) (2019)
Gilles R Dagenais, Hyejung Jung, Peter Bogaty, Jackie Bosch, Salim Yusuf, Ulagamadesan Venkatesan
Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial. Diabetes, obesity & metabolism 21 (6) (2019)
Marie Pigeyre, Jennifer Sjaarda, Shihong Mao, Michael Chong, Sibylle Hess, Salim Yusuf, Ulagamadesan Venkatesan, Guillaume Paré
Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk. Diabetes care 42 (9) (2019)
Ulagamadesan Venkatesan, Vidhya Nair, Ruchi Chaube, Heidi Stoute, Geoff Werstuck
Dysglycemia and the Density of the Coronary Vasa Vasorum. Diabetes care 42 (5) (2019)
Cole D Bendor, Aya Bardugo, Inbar Zucker, Tali Cukierman-Yaffe, Miri Lutski, Estela Derazne, Tammy Shohat, Ofri Mosenzon, Dorit Tzur, Ari Sapir, Orit Pinhas-Hamiel, Richard G Kibbey, Itamar Raz, Arnon Afek, Ulagamadesan Venkatesan, Amir Tirosh, Gilad Twig
Childhood Pancreatitis and Risk for Incident Diabetes in Adulthood. Diabetes care 43 (1) (2019)
Kåre Inge Birkeland, Valdemar Grill, Cecilie Wium, Matthew J McQueen, Patricio Lopez-Jaramillo, Shun Fu Lee, Ulagamadesan Venkatesan
The association of basal insulin treatment versus standard care with outcomes in anti-GAD positive and negative subjects: A post-hoc analysis of the ORIGIN trial. Diabetes, obesity & metabolism 21 (2) (2018)
Ulagamadesan Venkatesan, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Matthew C Riddle, Lars Rydén, Denis Xavier, Charles M Atisso, Alvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C Cushman, Edward Franek, Nicolae Hancu, Markolf Hanefeld, Shaun Holt, Petr Jansky, Matyas Keltai, Fernando Lanas, Lawrence Alan Leiter, Patricio Lopez-Jaramillo, Ernesto G Cardona-Munoz, Valdis Pirags, Nana Pogosova, Peter J Raubenheimer, Jonathan Edward Shaw, Wayne H-H Sheu, Theodora Temelkova-Kurktschiev, null null
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Diabetes, obesity & metabolism 20 (1) (2017)
Ulagamadesan Venkatesan, Eleuterio Ferrannini, Matthew C Riddle, Salim Yusuf, null null
Insulin resistance and cardiovascular outcomes in the ORIGIN trial. Diabetes, obesity & metabolism 20 (3) (2017)